Use of Novel Antithrombotic Agents for COVID-19: Systemic Summary of Ongoing Randomized Controlled Trials

CONCLUSION: Some novel antithrombotic agents have pleiotropic anti-inflammatory and antiviral effects, which may help reduce the viral load or fibrosis, and improve oxygenation. Results from ongoing RCTs will elucidate their actual role in the management of patients with COVID-19.PMID:34538017 | DOI:10.1111/jth.15533

Source: Thrombosis and Haemostasis - September 19, 2021 Category: Hematology Authors: Azita H Talasaz Parham Sadeghipour Maryam Aghakouchakzadeh Hessam Kakavand Hamid Ariannejad Jean M Connors Beverley J Hunt Jeffrey S Berger Benjamin W Van Tassell Saskia Middeldorp Gregory Piazza Jeffrey I Weitz Mary Cushman Gregory Y H Lip Samuel Z Goldh Source Type: research